{"id":2443,"date":"2014-03-06T09:32:05","date_gmt":"2014-03-06T09:32:05","guid":{"rendered":"http:\/\/k2info.w.uib.no\/?p=2443"},"modified":"2014-04-04T11:26:02","modified_gmt":"2014-04-04T11:26:02","slug":"nye-publikasjoner-11","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/en\/2014\/03\/06\/nye-publikasjoner-11\/","title":{"rendered":"Nye publikasjonerNew Publications"},"content":{"rendered":"

Uke 10\/2014.<\/strong><\/p>\n

Week 10\/2014.<\/strong><\/p>\n

<\/p>\n

Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.<\/a>
\nWerner HM, Trovik J, Halle MK, Wik E, Akslen LA, Birkeland E, Bredholt T, Tangen IL, Krakstad C, Salvesen HB.
\nPLoS One. 2014 Feb 25;9(2):e90141. PMID: 24587245<\/p>\n

Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.<\/a>
\nGavasso S, Mosleth EF, Mar\u00f8y T, J\u00f8rgensen K, Nakkestad HL, Gjertsen BT, Myhr KM, Vedeler C.
\nPLoS One. 2014 Feb 19;9(2):e88632. PMID: 24586361<\/p>\n

Loss-of-function mutations in SLC30A8 protect against type 2 diabetes.
\n<\/a>Flannick J, Thorleifsson G, Beer NL, Jacobs SB, Grarup N, Burtt NP, Mahajan A, Fuchsberger C, Atzmon G, Benediktsson R, Blangero J, Bowden DW, Brandslund I, Brosnan J, Burslem F, Chambers J, Cho YS, Christensen C, Douglas DA, Duggirala R, Dymek Z, Farjoun Y, Fennell T, Fontanillas P, Fors\u00e9n T, Gabriel S, Glaser B, Gudbjartsson DF, Hanis C, Hansen T, Hreidarsson AB, Hveem K, Ingelsson E, Isomaa B, Johansson S, J\u00f8rgensen T, J\u00f8rgensen ME, Kathiresan S, Kong A, Kooner J, Kravic J, Laakso M, Lee JY, Lind L, Lindgren CM, Linneberg A, Masson G, Meitinger T, Mohlke KL, Molven A, Morris AP, Potluri S, Rauramaa R, Ribel-Madsen R, Richard AM, Rolph T, Salomaa V, Segr\u00e8 AV, Sk\u00e4rstrand H, Steinthorsdottir V, Stringham HM, Sulem P, Tai ES, Teo YY, Teslovich T, Thorsteinsdottir U, Trimmer JK, Tuomi T, Tuomilehto J, Vaziri-Sani F, Voight BF, Wilson JG, Boehnke M, McCarthy MI, Nj\u00f8lstad PR, Pedersen O, Groop L, Cox DR, Stefansson K, Altshuler D.
\nNat Genet. 2014 Mar 2. PMID: 24584071<\/p>\n

The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy.
\n<\/a>Austreid E, Lonning PE, Eikesdal HP.
\nExpert Opin Pharmacother. 2014 Feb 28. PMID: 24579888<\/p>\n

Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study).
\n<\/a>Mancusi C, Gerdts E, De Simone G, Abdelhai YM, L\u00f8nnebakken MT, Boman K, Wachtell K, Dahl\u00f6f B, Devereux RB.
\nBlood Press. 2014 Feb 24. PMID: 24564262<\/p>\n

Basert p\u00e5 siste ukes s\u00f8k p\u00e5<\/i><\/b> \u201c<\/i>Department of Clinical Science AND Bergen<\/i><\/strong>\u201d. Hvis du har publikasjoner som ikke favnes av dette s\u00f8ket, send referansen til olivera.bozickovic@k2.uib.no<\/a>.<\/i><\/p>\n

Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.<\/a>
\nWerner HM, Trovik J, Halle MK, Wik E, Akslen LA, Birkeland E, Bredholt T, Tangen IL, Krakstad C, Salvesen HB.
\nPLoS One. 2014 Feb 25;9(2):e90141. PMID: 24587245<\/p>\n

Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.<\/a>
\nGavasso S, Mosleth EF, Mar\u00f8y T, J\u00f8rgensen K, Nakkestad HL, Gjertsen BT, Myhr KM, Vedeler C.
\nPLoS One. 2014 Feb 19;9(2):e88632. PMID: 24586361<\/p>\n

Loss-of-function mutations in SLC30A8 protect against type 2 diabetes.
\n<\/a>Flannick J, Thorleifsson G, Beer NL, Jacobs SB, Grarup N, Burtt NP, Mahajan A, Fuchsberger C, Atzmon G, Benediktsson R, Blangero J, Bowden DW, Brandslund I, Brosnan J, Burslem F, Chambers J, Cho YS, Christensen C, Douglas DA, Duggirala R, Dymek Z, Farjoun Y, Fennell T, Fontanillas P, Fors\u00e9n T, Gabriel S, Glaser B, Gudbjartsson DF, Hanis C, Hansen T, Hreidarsson AB, Hveem K, Ingelsson E, Isomaa B, Johansson S, J\u00f8rgensen T, J\u00f8rgensen ME, Kathiresan S, Kong A, Kooner J, Kravic J, Laakso M, Lee JY, Lind L, Lindgren CM, Linneberg A, Masson G, Meitinger T, Mohlke KL, Molven A, Morris AP, Potluri S, Rauramaa R, Ribel-Madsen R, Richard AM, Rolph T, Salomaa V, Segr\u00e8 AV, Sk\u00e4rstrand H, Steinthorsdottir V, Stringham HM, Sulem P, Tai ES, Teo YY, Teslovich T, Thorsteinsdottir U, Trimmer JK, Tuomi T, Tuomilehto J, Vaziri-Sani F, Voight BF, Wilson JG, Boehnke M, McCarthy MI, Nj\u00f8lstad PR, Pedersen O, Groop L, Cox DR, Stefansson K, Altshuler D.
\nNat Genet. 2014 Mar 2. PMID: 24584071<\/p>\n

The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy.
\n<\/a>Austreid E, Lonning PE, Eikesdal HP.
\nExpert Opin Pharmacother. 2014 Feb 28. PMID: 24579888<\/p>\n

Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study).
\n<\/a>Mancusi C, Gerdts E, De Simone G, Abdelhai YM, L\u00f8nnebakken MT, Boman K, Wachtell K, Dahl\u00f6f B, Devereux RB.
\nBlood Press. 2014 Feb 24. PMID: 24564262<\/p>\n

Based on last week\u2019s search for<\/b><\/i><\/b> \u201c<\/i>Department of Clinical Science AND Bergen<\/i><\/strong>\u201d.<\/i> If you have publications which are not covered by this search, send the reference to <\/i><\/b>olivera.bozickovic@k2.uib.no<\/i><\/b><\/a>.<\/i><\/b><\/p>","protected":false},"excerpt":{"rendered":"

Uke 10\/2014. Week 10\/2014.<\/p>\n

Read more →<\/a><\/p>","protected":false},"author":2812,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43440],"tags":[],"class_list":["post-2443","post","type-post","status-publish","format-standard","hentry","category-nye-publikasjoner-i-embase"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/2443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/users\/2812"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/comments?post=2443"}],"version-history":[{"count":2,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/2443\/revisions"}],"predecessor-version":[{"id":2446,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/2443\/revisions\/2446"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/media?parent=2443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/categories?post=2443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/tags?post=2443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}